Clinical trial
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00143611 |
|---|---|
| Title | Efficacy & Safety of Resatorvid in Adults With Severe Sepsis |
| Official title | A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | Resatorvid, Placebo |
| Enrollment | 277 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 2, 2005 |
| Last update posted | Feb 2, 2012 |
| Countries | Australia, Austria, Belgium, Canada, Czechia, Finland, Germany, Israel, Italy, Japan, Netherlands, New Zealand and 5 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: